From GSK Pharma To MakeMyTrip: ICICI Securities Highlights Key Post-Q1 Opportunities

ICICI Securities remains constructive on Archean Chemical, GSK Pharma, MakeMyTrip and Nexus Select, citing improving earnings visibility, growth investments, market-share gains and sustained demand trends across sectors.